A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CECT / contrast-enhanced CT

[Related PubMed/MEDLINE]
Total Number of Papers: 239
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CECT  (>> Co-occurring Abbreviation)
Long Form:   contrast-enhanced CT
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Diagnostic Algorithm That Combines Quantitative 18F-FDG PET Parameters and Contrast-Enhanced CT Improves Posttherapeutic Locoregional Restaging and Prognostication of Survival in Patients With Esophageal Cancer. AUC, EC, MTV
2019 Acute kidney injury following contrast media administration in the septic patient: A retrospective propensity-matched analysis. AKI, CM, ED, SCr
2019 Advantages of Intraprocedural Unenhanced CT During Adrenal Venous Sampling to Confirm Accurate Catheterization of the Right Adrenal Vein. AVS, RAV
2019 Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI? ---
2019 Comparison of characteristic computed tomographic findings of gastrointestinal and non-gastrointestinal stromal tumors in the small intestine. CT, GISTs
2019 Computer-Aided Detection of Pulmonary Nodules in Computed Tomography Using ClearReadCT. CAD, CT, PNL
2019 CT and MR imaging findings of infection-free and benign second branchial cleft cysts. SBCCs
2019 CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma. HPV
2019 Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images. ---
10  2019 Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. AUC, hypo-PNETs, PDAC
11  2019 Differentiation of Kawasaki Disease From Other Causes of Fever and Cervical Lymphadenopathy: A Diagnostic Scoring System Using Contrast-Enhanced CT. KD
12  2019 Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images. CTTA, FNH, HAP, HCA, PVP, TexRAD
13  2019 Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. ---
14  2019 Mediastinal Duplication Cyst on 99mTc Pertechnetate Scan. ---
15  2019 Pericardial injury with cardiac tamponade and bleeding from the pericardium confirmed using contrast-enhanced computed tomography: a case report. CT, FAST
16  2019 Prospective comparison of (4S)-4-(3-18F-fluoropropyl)-L-glutamate versus 18F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. CT, FDG, PDAC, PET, xCT
17  2018 Accuracy of semi-automated versus manual localisation of liver tumours in CT-guided ablation procedures. CT, PACS, TRE, VUCT
18  2018 Allergic-like contrast reactions in the ED: Incidence, management, and impact on patient disposition. ALCR, ED
19  2018 Bilateral multifocal acute lobar nephronia caused by Enterococcus faecalis. ALN
20  2018 Comparative effectiveness of 18F-FDG PET-CT and contrast-enhanced CT in the diagnosis of suspected large-vessel vasculitis. AUC, LVV, ROC, SD
21  2018 Comparing diagnostic accuracy of 18F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections. NPV, PPV, VGI
22  2018 Diagnostic accuracy of non-contrast abdominal CT scans performed as follow-up for patients with an established cancer diagnosis: a retrospective study. CRFs, NECT
23  2018 Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping. ---
24  2018 Effect of contrast material injection duration on arterial enhancement at CT in patients with various cardiac indices: Analysis using computer simulation. BW, CM, CTA, HU, PCTN
25  2018 Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis. AP, DM, OF, OGTT, ON, PCD, PN
26  2018 F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma. FDG, MC, PET/CT
27  2018 Frequency-selective non-linear blending for the computed tomography diagnosis of acute gangrenous cholecystitis: Pilot retrospective evaluation. AC
28  2018 Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography. CEUS, EOB-MRI, HCC, RFA
29  2018 Implications of iodinated contrast media extravasation in the emergency department. ED, LOS
30  2018 Improved detection rates and treatment planning of head and neck cancer using dual-layer spectral CT. DLSCT, HNC, HU, MonoE40
31  2018 Percutaneous puncture and embolisation for pancreatitis-related pseudoaneurysm: the feasibility of thrombin injection even in collection of fluid surrounding the pseudoaneurysm. CT, TAE
32  2018 Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. CT, PCa, PET
33  2018 Quantitative computed tomography texture analyses for anterior mediastinal masses: Differentiation between solid masses and cysts. AUC, CT, UECT
34  2018 Recommendations on nuclear and multimodality imaging in IE and CIED infections. ESC, IE
35  2018 Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center. NSCLC
36  2018 Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging. ---
37  2018 Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma? LAGC
39  2018 The effect of abdominal contrast-enhanced CT on DNA double-strand breaks in peripheral blood lymphocytes: an in vitro and in vivo study. CT, DSBs
40  2018 Thrombus Enhancement Is a Predictor of Clinical Outcome in Acute Ischemic Stroke after Mechanical Thrombectomy. CE, CT, mRS, MT, NECT
41  2018 Undifferentiated carcinoma with osteoclast-like giant cells of pancreas: A case report with review of the computed tomography findings. CA125, CA199, CEA, CT, CTA, UC-OGCs, US
42  2018 Utility of contrast-enhanced computed tomography in the evaluation of canine insulinoma location. ---
43  2018 What is the underestimation of radiation dose to the pediatric thyroid gland from contrast enhanced CT, if contrast medium uptake is not taken into account? ---
44  2018 Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India. FDG, LABC, PET/CT
45  2017 18F-FDG PET/CT and contrast-enhanced CT findings of pulmonary cryptococcosis. SUV
46  2017 Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography. BP, IgG4-aortitis, IgG4-RD, TBR
47  2017 Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations. CT, HU, NECT
48  2017 Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. CRS, HIPEC
49  2017 Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology? ---
50  2017 Detection of cartilage invasion in laryngeal carcinoma with dynamic contrast-enhanced CT. DCE-CT
51  2017 Emergency assessment of patients with acute abdominal pain using low-dose CT with iterative reconstruction: a comparative study. BMI, LDCT
52  2017 Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRI. CV, HBP, ICC, LSN, NCT, T1W, T2W
53  2017 Impact of intravenous contrast used in computed tomography on radiation dose to carotid arteries and thyroid in intensity-modulated radiation therapy planning for nasopharyngeal carcinoma. CT, IMRT, NCE-CT, NPC, OARs
54  2017 Improved CT-detection of acute bowel ischemia using frequency selective non-linear image blending. CT, F-NLB
55  2017 Influence of computed tomography contrast agent on radiotherapy dose calculation for pancreatic carcinoma: A dosimetric study based on tomotherapy and volumetric-modulated arc therapy techniques. CT, TOMO, VMAT
56  2017 Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis - An animal experimental prospective cohort study. DWI, MVD, NSCLC, TOF
57  2017 Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging. HL, PET/CT, RIW
58  2017 Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. CNR, DCE-MRI, liposomal-Gd
59  2017 Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma. CT, HNSCC, PET
60  2017 Primary Pleuropulmonary Synovial Sarcoma on Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan. FDG PET-CT
61  2017 Prospective comparison of biphasic contrast-enhanced CT, volume perfusion CT, and 3 Tesla MRI with diffusion-weighted imaging for insulinoma detection. DWI, VPCT
62  2017 Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. CRLM
63  2017 Prospective Evaluation of Reduced Dose Computed Tomography for the Detection of Low-Contrast Liver Lesions: Direct Comparison with Concurrent Standard Dose Imaging. median, 1.71, RD, SD
64  2017 Pulmonary Arteriovenous Malformations Embolized Using a Micro Vascular Plug System: Technical Note on a Preliminary Experience. HHT, MVP, PAVMs
65  2017 Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. AUC, CT, LTET, SSFs, TET, UECT
66  2017 Sensation of smell and taste during intravenous injection of iodinated contrast media in CT examinations. CM
67  2017 Spontaneous bladder rupture: unusual presentation in a haemophilic child. ---
68  2017 Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip Cartilage. ---
69  2017 Three-Dimensional Image Fusion of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Contrast-Enhanced Computed Tomography for Computer-Assisted Planning of Maxillectomy of Recurrent Maxillary Squamous Cell Carcinoma and Defect Reconstruction. CT, FDG, PET
70  2017 Trauma in pregnant women: assessing detection of post-traumatic placental abruption on contrast-enhanced CT versus ultrasound. US
71  2016 Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT. ---
72  2016 Analysis of iodinated contrast delivered during thermal ablation: is material trapped in the ablation zone? CNR
73  2016 Assessment of Added Value of Noncontrast to Contrast-Enhanced Abdominal Computed Tomography Scan for Characterization of Hypervascular Liver Metastases. NECT
74  2016 Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models. CT/MR, HCC, ICA, IRA, LI-RADS, LS
75  2016 Comparison of 68Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome. ACTH, CT, HU, PET, PPV
76  2016 Contrast-enhanced CT using a cationic contrast agent enables non-destructive assessment of the biochemical and biomechanical properties of mouse tibial plateau cartilage. GAG, OA
77  2016 Correlating MDCT Liver Injury Grade and Clinical Outcome in Patients Without Significant Extra-hepatic Injury. MDCT
78  2016 Detection of compressive hydrated nucleus pulposus extrusion in dogs with multislice computed tomography. CT, HNPE, MRI
79  2016 Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI. ASR, CSMRI, SII
80  2016 Diagnostic Usefulness of Low-Dose Nonenhanced Computed Tomography With Coronal Reformations in Patients With Suspected Acute Appendicitis: A Comparison With Standard-Dose Computed Tomography. LD, NECT, SD
81  2016 Does angiography increase the risk of impairment in renal function during non-operative management of patients with blunt splenic injuries? A cross-sectional study in southern Taiwan. BSIs, CIN, eGFR, Hb, SCr
82  2016 Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors. ED, Ga-DOTATOC, NETs
83  2016 Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. NRI, SPN
84  2016 FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. AUC, FDG, HNSCC
85  2016 FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions. FLT
86  2016 Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas. CT, PET
87  2016 Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0. CLM, MTV, OS, TLG
88  2016 No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer. FCH, neCT, PCa, PET
89  2016 Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma. HCC, PET, SUV, T/B, T/B, VOIs
90  2016 Post-traumatic liver and splenic pseudoaneurysms in children: Diagnosis, management, and follow-up screening using contrast enhanced ultrasound (CEUS). CEUS, ISS, PA
91  2016 Role of 64 slice multidetector computed tomography and angiography to establish relationship between tumor size, aneurysm formation and spontaneous rupture of renal angiomyolipomas: Single center experience. AML, CT
92  2016 Thrombus length discrepancy on dual-phase CT can predict clinical outcome in acute ischemic stroke. CTA
93  2016 Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast-Enhanced CT. ---
94  2016 [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy. BS, CT, FDG, PET
95  2015 (18)F-FDG-PET/CT findings in pancreatic metastasis. ---
96  2015 Consistency analysis of contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis of small hepatocellular carcinoma. CEUS, HCC
97  2015 Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy. CT, RECIST
98  2015 Contrast-enhanced CT facilitates rapid, non-destructive assessment ofcartilage and bone properties of the human metacarpal. DMMB, OA, SBP
99  2015 Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. NPV, PC, PET/CT
100  2015 CT vs. MRCP in choledocholithiasis jaundice. CBD, CT, ERCP, MRCP